Viking Therapeutics, Inc.
VKTX
$33.88
-$0.67-1.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -139.43% | -77.32% | -36.83% | -28.02% | -22.64% |
| Total Depreciation and Amortization | 44.19% | 41.89% | 30.27% | 18.49% | 6.90% |
| Total Amortization of Deferred Charges | -16.67% | 29.73% | 2.27% | 6.82% | 37.14% |
| Total Other Non-Cash Items | 117.42% | 160.77% | 45.98% | 44.00% | 30.58% |
| Change in Net Operating Assets | -213.42% | -143.27% | -177.59% | 163.87% | 172.09% |
| Cash from Operations | -202.46% | -112.02% | -144.20% | -19.64% | -11.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 151.96% | 124.57% | 95.27% | -208.99% | -152.56% |
| Cash from Investing | 151.96% | 124.57% | 95.27% | -208.99% | -152.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.64% | -99.33% | -99.26% | 134.97% | 125.29% |
| Repurchase of Common Stock | 100.00% | 100.00% | 100.00% | -485.14% | -411.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.62% | -99.28% | -99.22% | 125.69% | 116.95% |
| Foreign Exchange rate Adjustments | -279.17% | -80.95% | -43.48% | -393.33% | -139.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 280.10% | 60.81% | -188.95% | -252.72% | 69.24% |